CDC-RFA-CK21-2103: Enhancing Regional Capacity for Vector Surveillance and Control in the US territories in the Caribbean
Closed
This grant is closed. A newer notice from the same program is open now: NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) (PA-27-100). Status: Due dates in the notice, expires April 5, 2027. It is in our archive of Centers for Disease Control - NCEZID notices from 2021.
Centers for Disease Control - NCEZID offered grants of up to $5.0 million (at least $100,000) to nonprofits. It expected to make one award worth $25.0 million in total. Applications closed on May 7, 2021.
From the official notice on Grants.gov, last changed March 22, 2021. Checked November 7, 2026.
- Award ceiling$5.0 million
- Award floor$100,000
- Total funding$25.0 million
- Expected awards1
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | March 22, 2021 |
|---|---|
| Deadline | May 7, 2021 |
| Archived by Grants.gov | June 6, 2021 |
Who can apply
This opportunity was open to nonprofits.
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Puerto Rico Science, Technology and Research Trust
Is this a realistic fit?
- Past Prevention of Disease, Disability, and Death by Infectious Diseases awards averaged $1.9 million; this notice allows up to $5.0 million per award.
- No cost sharing or match is required.
What the grant funds
The recipient will serve as a partner on mosquito surveillance and control strategy development and implementation. Through the cooperative agreement mechanism, the recipient will collaborate with CDC in providing technical support and guidance to state and local vector control programs as they build up, implement, evaluation and/or enhance vector surveillance, control, and insecticide resistance (IR) testing activities in the jurisdiction. Topic areas may include but are not limited to: Workshops and Trainings on Vector Surveillance and Control for mosquitoes Develop a professional network between CDC and the jurisdiction Develop and implement an educational tool kit and outreach program on mosquito control Produce and evaluate insecticide resistance (IR) testing and data for decision making
Who has won Prevention of Disease, Disability, and Death by Infectious Diseases grants before
From fiscal 2021 to 2025, Prevention of Disease, Disability, and Death by Infectious Diseases (93.084) awarded $241 million across 128 grant awards, an average of $1.9 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Puerto Rico Science, Technology, and Research Trust | Puerto Rico | 4 | $14.5 million |
| Massachusetts Department of Public Health | Massachusetts | 1 | $11.6 million |
| Emory University | Georgia | 3 | $11.5 million |
| Uganda Virus Research Institute | 1 | $8.7 million | |
| Ponce Medical School Foundation Inc | Puerto Rico | 2 | $8.7 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, PA-27-100, which is open now.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is CDC-RFA-CK21-2103 still open?
No. It closed on May 7, 2021. A newer notice is open: PA-27-100, due dates in the notice, expires April 5, 2027.
Who can apply for Enhancing Regional Capacity for Vector Surveillance and Control in the US territories in the Caribbean?
Centers for Disease Control - NCEZID accepted applications from nonprofits. The notice adds further conditions, so read its eligibility section.
What is the deadline for Enhancing Regional Capacity for Vector Surveillance and Control in the US territories in the Caribbean?
Closed May 7, 2021. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $5.0 million each. About $25.0 million in total for one award.
Who has won Prevention of Disease, Disability, and Death by Infectious Diseases grants before?
The largest recipients over five fiscal years were Puerto Rico Science, Technology, and Research Trust, Massachusetts Department of Public Health, Emory University. The program made 128 awards worth $241 million in that time.
Similar open grants
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)